| 000 | 01892 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515110345.0 | ||
| 264 | 0 | _c20090401 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1353-8020 | ||
| 024 | 7 |
_a10.1016/S1353-8020(08)70023-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQian, Li | |
| 245 | 0 | 0 |
_aNADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation. _h[electronic resource] |
| 260 |
_bParkinsonism & related disorders _c2007 |
||
| 300 |
_aS316-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBrain _xcytology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aMicroglia _xdrug effects |
| 650 | 0 | 4 |
_aNADPH Oxidases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeurons _xcytology |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNitrites _xmetabolism |
| 650 | 0 | 4 |
_aOnium Compounds _xpharmacology |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aGao, Xi | |
| 700 | 1 | _aPei, Zhong | |
| 700 | 1 | _aWu, Xuefei | |
| 700 | 1 | _aBlock, Michelle | |
| 700 | 1 | _aWilson, Belinda | |
| 700 | 1 | _aHong, Jau-Shyong | |
| 700 | 1 | _aFlood, Patrick M | |
| 773 | 0 |
_tParkinsonism & related disorders _gvol. 13 Suppl 3 _gp. S316-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1353-8020(08)70023-3 _zAvailable from publisher's website |
| 999 |
_c17772392 _d17772392 |
||